Oxatomide
Top View
- Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
- Combined Deep Learning and Molecular Docking Simulations to Identify Most Promising Candidates from the List of FDA Approved Drugs That Can Be Repurposed to Treat
- Npgrj NCHEMBIO 806 415..416
- Oxatomide(KW・4354)の 薬 理作用(第5報)
- A Review on Fast Dissolving Tablets
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Oxatomide Inhibits Interleukin-8 Release from Respiratory Epithelial Cells*
- H1‐Antihistamines for Primary Mast Cell Activation Syndromes (MCAS): a Systematic Review
- The Calculation of Physicochemical Descriptors and Their Application in Predicting Properties of Drugs and Other Compounds
- Management of Drug Overdose and Poisoning
- Use of Antihistamines in Pediatrics a Del Cuvillo,1 J Sastre,2 J Montoro,3 I Jáuregui,4 M Ferrer,5 I Dávila,6 J Bartra,7 J Mullol,8 a Valero,7
- Bioactive Compound Library Plus (96-Well)
- Wo 2007/044693 A2
- Pheniramine Maleate
- Guidance Document on Using in Vitro Data to Estimate in Vivo Starting Doses for Acute Toxicity
- 5-HT Receptor Serotonin Receptor; 5-Hydroxytryptamine Receptor
- Mosser Et Al Figs 190702
- United States Patent (19) (11) Patent Number: 5,250,529 Theoharides 45) Date of Patent: Oct